Product Design, Manufacturing & Innovation Resources
» 重组DNA(rDNA)

重组DNA(rDNA)

1973
  • Stanley Norman Cohen
  • Herbert Boyer
在实验室进行 DNA 重组技术研究的分子生物学家。.

(图片仅供参考)

重组DNA (rDNA) 技术涉及将来自两个不同物种的DNA分子连接在一起。将重组DNA插入宿主生物体,产生新的基因组合。这一技术利用限制性内切酶在特定位点切割DNA,再用DNA连接酶连接片段,通常将所需基因整合到质粒载体中进行克隆。

Recombinant DNA technology, also known as genetic engineering, is the process of creating artificial DNA by combining genetic material from different sources. This technology fundamentally changed biology and medicine by allowing scientists to directly manipulate the genetic code of organisms. The core procedure involves several key steps. First, a gene of interest is identified and isolated from a source organism’s DNA. This is often done using restriction enzymes, which are proteins that act like molecular scissors, cutting DNA at specific recognition sequences. Second, a vector, which is a DNA molecule used to carry the foreign genetic material into another cell, is chosen. Bacterial plasmids—small, circular DNA molecules separate from the bacterial chromosome—are the most common vectors. The same restriction enzyme used to cut out the gene is used to cut open the plasmid vector. This creates compatible ‘sticky ends’ on both the gene and the plasmid. Third, the isolated gene is inserted into the plasmid. The sticky ends of the gene anneal with the complementary sticky ends of the plasmid, and the enzyme DNA ligase is added to permanently join them by forming phosphodiester bonds. The resulting molecule is a recombinant plasmid containing the new gene. Finally, this recombinant vector is introduced into a host organism, typically a bacterium like *E. coli*, through a process called transformation. As the host cells multiply, they replicate the recombinant plasmid along with their own DNA, creating many copies of the inserted gene. The host cells can also transcribe and translate the foreign gene to produce the desired protein, such as human insulin produced in bacteria.

UNESCO Nomenclature: 2406
- 分子生物学

类型

化学过程

中断

革命

用法

广泛使用

前体

  • 发现DNA作为遗传物质
  • DNA双螺旋结构的阐明
  • 细菌中质粒的发现
  • 限制性内切酶的发现和表征,作者:Werner Arber、Daniel Nathans 和 Hamilton Smith
  • DNA连接酶的发现

应用程序

  • 生产用于糖尿病患者的合成人胰岛素
  • 创造转基因生物(GMO)
  • 疫苗生产(例如乙肝疫苗)
  • 基因治疗
  • 血友病凝血因子的产生

专利:

  • US4237224

潜在创新理念

由于机器人流量被拦截(目前每天超过 4 万),此内容仅限社区成员查看。
> 登录 > 或者 > 注册 < (100% 免费)即可访问此内容,以及所有其他受限内容和工具。

相关内容: 重组 DNA、基因工程、斯坦利-科恩、赫伯特-博耶、质粒、载体、限制酶、DNA 连接酶、基因克隆、转基因生物。.

历史背景

重组DNA(rDNA)

1958
1960
1970
1973
1975
1979
1983
1954
1960
1967
1970
1975
1977
1983
1987

(如果日期未知或不相关,例如“流体力学”,则提供其显著出现的近似估计)

相关发明、创新和技术原理

只有注册会员才能免费获得 100% 的全尺寸图片和下载。.

> 登录 <